Skip to main content
. 2024 Feb 8;20(4):2485–2496. doi: 10.1002/alz.13653

FIGURE 1.

FIGURE 1

Concentrations of plasma biomarkers in the DLB continuum and controls. Aβ, amyloid beta; CU, cognitively unimpaired; DLB, dementia with Lewy bodies; GFAP, glial fibrillary acid protein; iRBD, isolated rapid eye movement (REM) sleep behavior disorder; NfL, neurofilament light; MCI‐LB, mild cognitive impairment with Lewy bodies; p‐tau, phosphorylated tau.